APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pain Reliever

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pain Reliever Industry Growth and Trends Forecast to 2032

19 December 2025111 pages

Choose your research edition.

Industry ResearchPain Reliever Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Pain Reliever Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pain Reliever Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pain Reliever Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Pain Reliever Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Pain Reliever market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pain Reliever is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pain Reliever is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pain Reliever is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pain Reliever include Teva, Sanofi, J&J, Merck, Eli Lilly, Pfizer, GSK, Bayer and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pain Reliever market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pain Reliever market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pain Reliever market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pain Reliever.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pain Reliever market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pain Reliever Market by Company

Teva

Sanofi

J&J

Merck

Eli Lilly

Pfizer

GSK

Bayer

AstraZeneca

Yunnan Baiyao

Purdue

Grunenthal

Endo

Depomed

Allergan

Pain Reliever Segment by Type

Branded Opioids

NSAIDs

Generic Opioids

Others

Pain Reliever Segment by Application

Hospitals

Clinics

Drugstores

Pain Reliever Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Reliever market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pain Reliever and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Reliever.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pain Reliever manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pain Reliever in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Branded Opioids Table 2. Major Company of NSAIDs Table 3. Major Company of Generic Opioids Table 4. Major Company of Others Table 5. Global Pain Reliever Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Pain Reliever Sales by Type (2021-2026) & (K Units) Table 7. Global Pain Reliever Sales Market Share in Volume by Type (2021-2026) Table 8. Global Pain Reliever Sales by Type (2021-2026) & (US$ Million) Table 9. Global Pain Reliever Sales Market Share in Value by Type (2021-2026) Table 10. Global Pain Reliever Price by Type (2021-2026) & (US$/Unit) Table 11. Global Pain Reliever Sales by Type (2027-2032) & (K Units) Table 12. Global Pain Reliever Sales Market Share in Volume by Type (2027-2032) Table 13. Global Pain Reliever Sales by Type (2027-2032) & (US$ Million) Table 14. Global Pain Reliever Sales Market Share in Value by Type (2027-2032) Table 15. Global Pain Reliever Price by Type (2027-2032) & (US$/Unit) Table 16. North America Pain Reliever Sales by Type (2021-2026) & (K Units) Table 17. North America Pain Reliever Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Pain Reliever Sales by Type (2021-2026) & (K Units) Table 19. Europe Pain Reliever Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Pain Reliever Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Pain Reliever Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Pain Reliever Sales by Type (2021-2026) & (K Units) Table 23. Latin America Pain Reliever Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Pain Reliever Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Pain Reliever Sales by Type (2021-2026) & (US$ Million) Table 26. Pain Reliever Industry Trends Table 27. Pain Reliever Industry Drivers Table 28. Pain Reliever Industry Opportunities and Challenges Table 29. Pain Reliever Industry Restraints Table 30. Global Pain Reliever Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Pain Reliever Revenue Market Share by Company (2021-2026) Table 32. Global Pain Reliever Sales by Company (2021-2026) & (K Units) Table 33. Global Pain Reliever Sales Share by Company (2021-2026) Table 34. Global Pain Reliever Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Pain Reliever Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Pain Reliever Major Company Production Sites and Headquarters Table 37. Global Pain Reliever Company, Product Type & Application Table 38. Global Pain Reliever Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Pain Reliever by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Pain Reliever Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Pain Reliever Sales by Region (2021-2026) & (K Units) Table 43. Global Pain Reliever Sales Market Share in Volume by Region (2021-2026) Table 44. Global Pain Reliever Sales by Region (2021-2026) & (US$ Million) Table 45. Global Pain Reliever Sales Market Share in Value by Region (2021-2026) Table 46. Global Pain Reliever Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Pain Reliever Sales by Region (2027-2032) & (K Units) Table 48. Global Pain Reliever Sales Market Share in Volume by Region (2027-2032) Table 49. Global Pain Reliever Sales by Region (2027-2032) & (US$ Million) Table 50. Global Pain Reliever Sales Market Share in Value by Region (2027-2032) Table 51. Global Pain Reliever Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Pain Reliever Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Pain Reliever Sales by Application (2021-2026) & (K Units) Table 54. Global Pain Reliever Sales Market Share in Volume by Application (2021-2026) Table 55. Global Pain Reliever Sales by Application (2021-2026) & (US$ Million) Table 56. Global Pain Reliever Sales Market Share in Value by Application (2021-2026) Table 57. Global Pain Reliever Price by Application (2021-2026) & (US$/Unit) Table 58. Global Pain Reliever Sales by Application (2027-2032) & (K Units) Table 59. Global Pain Reliever Sales Market Share in Volume by Application (2027-2032) Table 60. Global Pain Reliever Sales by Application (2027-2032) & (US$ Million) Table 61. Global Pain Reliever Sales Market Share in Value by Application (2027-2032) Table 62. Global Pain Reliever Price by Application (2027-2032) & (US$/Unit) Table 63. North America Pain Reliever Sales by Application (2021-2026) & (K Units) Table 64. North America Pain Reliever Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Pain Reliever Sales by Application (2021-2026) & (K Units) Table 66. Europe Pain Reliever Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Pain Reliever Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Pain Reliever Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Pain Reliever Sales by Application (2021-2026) & (K Units) Table 70. Latin America Pain Reliever Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Pain Reliever Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Pain Reliever Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Teva Pain Reliever Product Portfolio Table 77. Teva Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sanofi Pain Reliever Product Portfolio Table 82. Sanofi Recent Development Table 83. J&J Company Information Table 84. J&J Business Overview Table 85. J&J Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. J&J Pain Reliever Product Portfolio Table 87. J&J Recent Development Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Merck Pain Reliever Product Portfolio Table 92. Merck Recent Development Table 93. Eli Lilly Company Information Table 94. Eli Lilly Business Overview Table 95. Eli Lilly Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Eli Lilly Pain Reliever Product Portfolio Table 97. Eli Lilly Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Pfizer Pain Reliever Product Portfolio Table 102. Pfizer Recent Development Table 103. GSK Company Information Table 104. GSK Business Overview Table 105. GSK Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. GSK Pain Reliever Product Portfolio Table 107. GSK Recent Development Table 108. Bayer Company Information Table 109. Bayer Business Overview Table 110. Bayer Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Bayer Pain Reliever Product Portfolio Table 112. Bayer Recent Development Table 113. AstraZeneca Company Information Table 114. AstraZeneca Business Overview Table 115. AstraZeneca Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. AstraZeneca Pain Reliever Product Portfolio Table 117. AstraZeneca Recent Development Table 118. Yunnan Baiyao Company Information Table 119. Yunnan Baiyao Business Overview Table 120. Yunnan Baiyao Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Yunnan Baiyao Pain Reliever Product Portfolio Table 122. Yunnan Baiyao Recent Development Table 123. Purdue Company Information Table 124. Purdue Business Overview Table 125. Purdue Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Purdue Pain Reliever Product Portfolio Table 127. Purdue Recent Development Table 128. Grunenthal Company Information Table 129. Grunenthal Business Overview Table 130. Grunenthal Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Grunenthal Pain Reliever Product Portfolio Table 132. Grunenthal Recent Development Table 133. Endo Company Information Table 134. Endo Business Overview Table 135. Endo Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Endo Pain Reliever Product Portfolio Table 137. Endo Recent Development Table 138. Depomed Company Information Table 139. Depomed Business Overview Table 140. Depomed Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Depomed Pain Reliever Product Portfolio Table 142. Depomed Recent Development Table 143. Allergan Company Information Table 144. Allergan Business Overview Table 145. Allergan Pain Reliever Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Allergan Pain Reliever Product Portfolio Table 147. Allergan Recent Development Table 148. North America Pain Reliever Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. North America Pain Reliever Sales by Country (2021-2026) & (K Units) Table 150. North America Pain Reliever Sales Market Share by Country (2021-2026) Table 151. North America Pain Reliever Sales Forecast by Country (2027-2032) & (K Units) Table 152. North America Pain Reliever Sales Market Share Forecast by Country (2027-2032) Table 153. North America Pain Reliever Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Pain Reliever Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Pain Reliever Market Share by Country (2021-2026) Table 156. North America Pain Reliever Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Pain Reliever Market Share Forecast by Country (2027-2032) Table 158. Europe Pain Reliever Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Europe Pain Reliever Sales by Country (2021-2026) & (K Units) Table 160. Europe Pain Reliever Sales Market Share by Country (2021-2026) Table 161. Europe Pain Reliever Sales Forecast by Country (2027-2032) & (K Units) Table 162. Europe Pain Reliever Sales Market Share Forecast by Country (2027-2032) Table 163. Europe Pain Reliever Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Pain Reliever Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Pain Reliever Market Share by Country (2021-2026) Table 166. Europe Pain Reliever Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Pain Reliever Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Pain Reliever Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Pain Reliever Sales by Country (2021-2026) & (K Units) Table 170. Asia-Pacific Pain Reliever Sales Market Share by Country (2021-2026) Table 171. Asia-Pacific Pain Reliever Sales Forecast by Country (2027-2032) & (K Units) Table 172. Asia-Pacific Pain Reliever Sales Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Pain Reliever Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Pain Reliever Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Pain Reliever Market Share by Country (2021-2026) Table 176. Asia-Pacific Pain Reliever Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Pain Reliever Market Share Forecast by Country (2027-2032) Table 178. Latin America Pain Reliever Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 179. Latin America Pain Reliever Sales by Country (2021-2026) & (K Units) Table 180. Latin America Pain Reliever Sales Market Share by Country (2021-2026) Table 181. Latin America Pain Reliever Sales Forecast by Country (2027-2032) & (K Units) Table 182. Latin America Pain Reliever Sales Market Share Forecast by Country (2027-2032) Table 183. Latin America Pain Reliever Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Latin America Pain Reliever Market Size by Country (2021-2026) & (US$ Million) Table 185. Latin America Pain Reliever Market Share by Country (2021-2026) Table 186. Latin America Pain Reliever Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Latin America Pain Reliever Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Pain Reliever Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Pain Reliever Sales by Country (2021-2026) & (K Units) Table 190. Middle East and Africa Pain Reliever Sales Market Share by Country (2021-2026) Table 191. Middle East and Africa Pain Reliever Sales Forecast by Country (2027-2032) & (K Units) Table 192. Middle East and Africa Pain Reliever Sales Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Pain Reliever Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Pain Reliever Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East and Africa Pain Reliever Market Share by Country (2021-2026) Table 196. Middle East and Africa Pain Reliever Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East and Africa Pain Reliever Market Share Forecast by Country (2027-2032) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Pain Reliever Distributors List Table 201. Pain Reliever Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Pain Reliever Image Figure 2. Global Pain Reliever Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pain Reliever Market Size (2021-2032) & (US$ Million) Figure 4. Global Pain Reliever Sales (2021-2032) & (K Units) Figure 5. Branded Opioids Image Figure 6. Global Branded Opioids Sales YoY Growth (2021-2032) & (K Units) Figure 7. NSAIDs Image Figure 8. Global NSAIDs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Generic Opioids Image Figure 10. Global Generic Opioids Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Pain Reliever Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Pain Reliever Market Share by Type 2025 VS 2032 Figure 15. North America Pain Reliever Sales Market Share in Volume by Type in 2025 Figure 16. North America Pain Reliever Sales Market Share in Value by Type in 2025 Figure 17. Europe Pain Reliever Sales Market Share in Volume by Type in 2025 Figure 18. Europe Pain Reliever Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Pain Reliever Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Pain Reliever Sales Market Share in Value by Type in 2025 Figure 21. Latin America Pain Reliever Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Pain Reliever Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Pain Reliever Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Pain Reliever Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Pain Reliever Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinics Image Figure 30. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 31. Drugstores Image Figure 32. Global Drugstores Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Pain Reliever Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Pain Reliever Market Share by Application 2025 VS 2032 Figure 35. North America Pain Reliever Sales Market Share in Volume by Application in 2025 Figure 36. North America Pain Reliever Sales Market Share in Value by Application in 2025 Figure 37. Europe Pain Reliever Sales Market Share in Volume by Application in 2025 Figure 38. Europe Pain Reliever Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Pain Reliever Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Pain Reliever Sales Market Share in Value by Application in 2025 Figure 41. Latin America Pain Reliever Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Pain Reliever Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Pain Reliever Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Pain Reliever Sales Market Share in Value by Application in 2025 Figure 45. North America Pain Reliever Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Pain Reliever Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Pain Reliever Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Pain Reliever Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pain Reliever Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Pain Reliever Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Pain Reliever Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Pain Reliever Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pain Reliever Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Pain Reliever Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Pain Reliever Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Pain Reliever Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pain Reliever Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Pain Reliever Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Pain Reliever Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Pain Reliever Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pain Reliever Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Pain Reliever Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Pain Reliever Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Pain Reliever Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Pain Reliever Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Pain Reliever Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Branded Opioids
  • NSAIDs
  • Generic Opioids
  • Others
Applications
  • Hospitals
  • Clinics
  • Drugstores
Companies covered
  • Teva
  • Sanofi
  • J&J
  • Merck
  • Eli Lilly
  • Pfizer
  • GSK
  • Bayer
  • AstraZeneca
  • Yunnan Baiyao
  • Purdue
  • Grunenthal
  • Endo
  • Depomed
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pain Reliever Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pain Reliever Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pain Reliever Market by Type
  6. 1.3.1 Branded Opioids
  7. 1.3.2 NSAIDs
  8. 1.3.3 Generic Opioids
  9. 1.3.4 Others
  10. 1.4 Global Pain Reliever Market Size by Type
  11. 1.4.1 Global Pain Reliever Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Pain Reliever Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Pain Reliever Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Pain Reliever Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Pain Reliever Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Pain Reliever Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Pain Reliever Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Pain Reliever Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pain Reliever Industry Trends
  2. 2.2 Pain Reliever Industry Drivers
  3. 2.3 Pain Reliever Industry Opportunities and Challenges
  4. 2.4 Pain Reliever Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pain Reliever Revenue (2021-2026)
  2. 3.2 Global Top Players by Pain Reliever Sales (2021-2026)
  3. 3.3 Global Top Players by Pain Reliever Price (2021-2026)
  4. 3.4 Global Pain Reliever Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pain Reliever Major Company Production Sites & Headquarters
  6. 3.6 Global Pain Reliever Company, Product Type & Application
  7. 3.7 Global Pain Reliever Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pain Reliever Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pain Reliever Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pain Reliever Tier 1, Tier 2, and Tier 3
4 Pain Reliever Regional Status and Outlook
  1. 4.1 Global Pain Reliever Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pain Reliever Historic Market Size by Region
  3. 4.2.1 Global Pain Reliever Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pain Reliever Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pain Reliever Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pain Reliever Forecasted Market Size by Region
  7. 4.3.1 Global Pain Reliever Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pain Reliever Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pain Reliever Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pain Reliever by Application
  1. 5.1 Pain Reliever Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Drugstores
  5. 5.2 Global Pain Reliever Market Size by Application
  6. 5.2.1 Global Pain Reliever Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pain Reliever Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pain Reliever Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pain Reliever Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pain Reliever Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pain Reliever Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pain Reliever Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pain Reliever Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pain Reliever Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Pain Reliever Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 J&J
  14. 6.3.1 J&J Company Information
  15. 6.3.2 J&J Business Overview
  16. 6.3.3 J&J Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 J&J Pain Reliever Product Portfolio
  18. 6.3.5 J&J Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Pain Reliever Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly Pain Reliever Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Pain Reliever Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GSK
  38. 6.7.1 GSK Company Information
  39. 6.7.2 GSK Business Overview
  40. 6.7.3 GSK Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GSK Pain Reliever Product Portfolio
  42. 6.7.5 GSK Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Pain Reliever Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca Pain Reliever Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 Yunnan Baiyao
  56. 6.10.1 Yunnan Baiyao Company Information
  57. 6.10.2 Yunnan Baiyao Business Overview
  58. 6.10.3 Yunnan Baiyao Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Yunnan Baiyao Pain Reliever Product Portfolio
  60. 6.10.5 Yunnan Baiyao Recent Developments
  61. 6.11 Purdue
  62. 6.11.1 Purdue Company Information
  63. 6.11.2 Purdue Business Overview
  64. 6.11.3 Purdue Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Purdue Pain Reliever Product Portfolio
  66. 6.11.5 Purdue Recent Developments
  67. 6.12 Grunenthal
  68. 6.12.1 Grunenthal Company Information
  69. 6.12.2 Grunenthal Business Overview
  70. 6.12.3 Grunenthal Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Grunenthal Pain Reliever Product Portfolio
  72. 6.12.5 Grunenthal Recent Developments
  73. 6.13 Endo
  74. 6.13.1 Endo Company Information
  75. 6.13.2 Endo Business Overview
  76. 6.13.3 Endo Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Endo Pain Reliever Product Portfolio
  78. 6.13.5 Endo Recent Developments
  79. 6.14 Depomed
  80. 6.14.1 Depomed Company Information
  81. 6.14.2 Depomed Business Overview
  82. 6.14.3 Depomed Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Depomed Pain Reliever Product Portfolio
  84. 6.14.5 Depomed Recent Developments
  85. 6.15 Allergan
  86. 6.15.1 Allergan Company Information
  87. 6.15.2 Allergan Business Overview
  88. 6.15.3 Allergan Pain Reliever Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Allergan Pain Reliever Product Portfolio
  90. 6.15.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Pain Reliever Sales by Country
  2. 7.1.1 North America Pain Reliever Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pain Reliever Sales by Country (2021-2026)
  4. 7.1.3 North America Pain Reliever Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pain Reliever Market Size by Country
  6. 7.2.1 North America Pain Reliever Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pain Reliever Market Size by Country (2021-2026)
  8. 7.2.3 North America Pain Reliever Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pain Reliever Sales by Country
  2. 8.1.1 Europe Pain Reliever Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pain Reliever Sales by Country (2021-2026)
  4. 8.1.3 Europe Pain Reliever Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pain Reliever Market Size by Country
  6. 8.2.1 Europe Pain Reliever Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pain Reliever Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pain Reliever Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pain Reliever Sales by Country
  2. 9.1.1 Asia-Pacific Pain Reliever Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pain Reliever Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pain Reliever Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pain Reliever Market Size by Country
  6. 9.2.1 Asia-Pacific Pain Reliever Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pain Reliever Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pain Reliever Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pain Reliever Sales by Country
  2. 10.1.1 South America Pain Reliever Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pain Reliever Sales by Country (2021-2026)
  4. 10.1.3 South America Pain Reliever Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pain Reliever Market Size by Country
  6. 10.2.1 South America Pain Reliever Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pain Reliever Market Size by Country (2021-2026)
  8. 10.2.3 South America Pain Reliever Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pain Reliever Sales by Country
  2. 11.1.1 Middle East and Africa Pain Reliever Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pain Reliever Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pain Reliever Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pain Reliever Market Size by Country
  6. 11.2.1 Middle East and Africa Pain Reliever Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pain Reliever Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pain Reliever Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pain Reliever Value Chain Analysis
  2. 12.1.1 Pain Reliever Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pain Reliever Production Mode & Process
  7. 12.2 Pain Reliever Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pain Reliever Distributors
  10. 12.2.3 Pain Reliever Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst